GRM2 and Parkinson disease: We now report that selective pharmacological activation of mGlu3 receptors enhancesthe production of GDNF in mouse striatum, and that the potent mGlu2/3 receptoragonist, LY379268, is highly protective in the MPTP model of parkinsonism at dosesthat up-regulate GDNF.